Answer
Lecanemab is a humanised IgG1 monoclonal antibody that binds selectively to aggregated amyloid beta, preferentially toxic soluble protofibrils, to neutralise and clear them from the brain, while showing low affinity for amyloid beta monomers.
Sources for this answer
- Leqembi 100 mg/mL concentrate for solution for infusionEisai Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 5Document updated
Sources checked